These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12475178)

  • 21. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau phosphorylation in neuronal cell function and dysfunction.
    Johnson GV; Stoothoff WH
    J Cell Sci; 2004 Nov; 117(Pt 24):5721-9. PubMed ID: 15537830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular factors modulating the mechanism of tau protein aggregation.
    Fontaine SN; Sabbagh JJ; Baker J; Martinez-Licha CR; Darling A; Dickey CA
    Cell Mol Life Sci; 2015 May; 72(10):1863-79. PubMed ID: 25666877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly.
    Feijoo C; Campbell DG; Jakes R; Goedert M; Cuenda A
    J Cell Sci; 2005 Jan; 118(Pt 2):397-408. PubMed ID: 15632108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal and pathological Tau proteins as factors for microtubule assembly.
    Delacourte A; Buée L
    Int Rev Cytol; 1997; 171():167-224. PubMed ID: 9066128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-translational modifications of tau protein in Alzheimer's disease.
    Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemistry of Tau in Alzheimer's disease and related neurological disorders.
    Sergeant N; Bretteville A; Hamdane M; Caillet-Boudin ML; Grognet P; Bombois S; Blum D; Delacourte A; Pasquier F; Vanmechelen E; Schraen-Maschke S; Buée L
    Expert Rev Proteomics; 2008 Apr; 5(2):207-24. PubMed ID: 18466052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New perspectives on the role of tau in Alzheimer's disease. Implications for therapy.
    Medina M; Avila J
    Biochem Pharmacol; 2014 Apr; 88(4):540-7. PubMed ID: 24462919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau.
    Li B; Chohan MO; Grundke-Iqbal I; Iqbal K
    Acta Neuropathol; 2007 May; 113(5):501-11. PubMed ID: 17372746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory roles of microtubule-associated proteins in neuronal morphogenesis. Involvement of the extracellular matrix.
    Ramírez G; Alvarez A; Garcia-Abreu J; Gomes FC; Moura Neto V; Maccioni RB
    Braz J Med Biol Res; 1999 May; 32(5):611-8. PubMed ID: 10412573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau protein kinases: involvement in Alzheimer's disease.
    Martin L; Latypova X; Wilson CM; Magnaudeix A; Perrin ML; Yardin C; Terro F
    Ageing Res Rev; 2013 Jan; 12(1):289-309. PubMed ID: 22742992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced miR-512 and the Elevated Expression of Its Targets cFLIP and MCL1 Localize to Neurons With Hyperphosphorylated Tau Protein in Alzheimer Disease.
    Mezache L; Mikhail M; Garofalo M; Nuovo GJ
    Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):615-23. PubMed ID: 26258756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoskeletal mechanisms of neuronal degeneration.
    Brandt R
    Cell Tissue Res; 2001 Aug; 305(2):255-65. PubMed ID: 11545263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
    J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention.
    Iqbal K; Grundke-Iqbal I
    Ann N Y Acad Sci; 1996 Jan; 777():132-8. PubMed ID: 8624075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
    Goedert M; Spillantini MG
    Biochim Biophys Acta; 2000 Jul; 1502(1):110-21. PubMed ID: 10899436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.